Brainxell

Brainxell company information, Employees & Contact Information

Explore related pages

Related company profiles:

Industry leading producer of neurons and glia paving the way for advancements in neuroscience. From the founding by Dr. Su-Chun Zhang, a pioneer in stem cell neuroscience, in collaboration with the University of Wisconsin–Madison’s Discovery to Product (D2P) program, BrainXell is translating cutting-edge research into discovery tools and potentially meaningful therapies. The team works with both large and small biotech and pharmaceutical partners to develop products, services, and applications using its proprietary technology to guide human stem cells—including induced pluripotent stem cells (iPSCs)—into highly enriched, specialized neurons. BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery. The focus of this team's research and production effort is based in Madison, WI. BrainXell Therapeutics is further advancing our experience based in San Diego, CA with a mission to bring novel therapies to patients with neurological disorders. The company’s lead program, BXT-110, is IND-enabling for Parkinson’s disease, and a second program targeting spinal cord injury is in early development. Learn more - visit us at brainxell.com and brainxelltx.com

Company Details

Employees
51
Founded
-
Address
455 Science Dr, Madison,wisconsin 53711,united States
Phone
608-220-3240
Email
in****@****ell.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Madison, Wisconsin
Looking for a particular Brainxell employee's phone or email?

Brainxell Questions

News

BrainXell, Inc. Strengthens Executive Leadership with Paul Marcus and Dr. Su-Chun Zhang - PR Newswire

BrainXell, Inc. Strengthens Executive Leadership with Paul Marcus and Dr. Su-Chun Zhang PR Newswire

BrainXell Success Story - WEDC

BrainXell Success Story WEDC

Brain cells by the billions: UW spinoff sells neural cells to drug researchers - University of Wisconsin–Madison

Brain cells by the billions: UW spinoff sells neural cells to drug researchers University of Wisconsin–Madison

New CEOs for Blackstone-backed Uniquity Bio and CNS cell provider Brainxell - BioCentury

New CEOs for Blackstone-backed Uniquity Bio and CNS cell provider Brainxell BioCentury

CNS Drug Discovery Using iPSC-Derived Neurons - Genetic Engineering and Biotechnology News

CNS Drug Discovery Using iPSC-Derived Neurons Genetic Engineering and Biotechnology News

BrainXell Enters Agreement for iPSC Patent Technology with iPS Academia Japan - BioInformant

BrainXell Enters Agreement for iPSC Patent Technology with iPS Academia Japan BioInformant

BrainXell, Inc. Appoints Katherine Vega Stultz as Chief Executive Officer and Board Director - PR Newswire

BrainXell, Inc. Appoints Katherine Vega Stultz as Chief Executive Officer and Board Director PR Newswire

ALS Drug Discovery via High-Throughput Phenotypic Screening Using iPSC-Derived Human Motor Neurons - Technology Networks

ALS Drug Discovery via High-Throughput Phenotypic Screening Using iPSC-Derived Human Motor Neurons Technology Networks

Top Brainxell Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant